Literature DB >> 15504131

Disseminated Scedosporium apiospermum infection in a previously healthy woman with HELLP syndrome.

J Riddell1, C E Chenoweth, C A Kauffman.   

Abstract

A previously healthy 33-year-old female died of disseminated infection with Scedosporium apiospermum in association with Hemolysis, Elevated Liver enzymes, and Low Platelets (HELLP) syndrome following the delivery of twins. Her postpartum course was complicated by multisystem organ failure managed with extracorporeal membrane oxygenation (ECMO). She also developed bowel and left lower extremity ischemia requiring surgical resection. Blood cultures yielded S. apiospermum, and histologic findings revealed in vivo adventitious sporulation, an unusual occurrence with this pathogen. Autopsy showed extensive fungal infection of brain, lungs, thyroid, heart, and kidneys.

Entities:  

Mesh:

Year:  2004        PMID: 15504131     DOI: 10.1111/j.1439-0507.2004.01015.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  3 in total

1.  Clinical and morphologic findings in disseminated Scedosporium apiospermum infections in immunocompromised patients.

Authors:  Molly M Campa-Thompson; James A West; Joseph M Guileyardo; Cedric W Spak; Louis M Sloan; Stacy G Beal
Journal:  Proc (Bayl Univ Med Cent)       Date:  2014-07

Review 2.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

3.  Extracorporeal Life Support in Pregnancy: A Systematic Review.

Authors:  Emily E Naoum; Andrew Chalupka; Jonathan Haft; Mark MacEachern; Cosmas J M Vandeven; Sarah Rae Easter; Michael Maile; Brian T Bateman; Melissa E Bauer
Journal:  J Am Heart Assoc       Date:  2020-06-24       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.